Home > Annual Financials > ZENOTECH LABORATORIES

ZENOTECH LABORATORIES Financial Statement Analysis
[BOM: 532039]

The Revenues of ZENOTECH LABORATORIES have decreased by -3.75% YoY .
The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by -32.35 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

ZENOTECH LABORATORIES Last 5 Annual Financial Results
[BOM: 532039]

StandaloneMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹41 Cr₹42 Cr₹37 Cr₹22 Cr₹26 Cr
Expenses ₹24 Cr₹22 Cr₹19 Cr₹16 Cr₹17 Cr
Operating Profit (Excl OI) ₹17 Cr₹21 Cr₹17 Cr₹6.38 Cr₹8.98 Cr
Other Income ₹1.01 Cr₹1.08 Cr₹0.63 Cr₹0.41 Cr₹1.17 Cr
Interest ₹0.00 Cr₹0.11 Cr₹1.22 Cr₹1.55 Cr₹0.89 Cr
Depreciation ₹7.09 Cr₹7.17 Cr₹6.97 Cr₹6.46 Cr₹4.85 Cr
Profit Before Tax ₹11 Cr₹15 Cr₹9.90 Cr₹-1.22 Cr₹11 Cr
Profit After Tax ₹8.30 Cr₹12 Cr₹22 Cr₹-1.22 Cr₹11 Cr
Earnings Per Share (Rs)₹0.92₹1.36₹1.90₹3.63₹-0.20
PAT Margin (%)13.0420.3227.3160.65-5.41
ROE(%)6.019.6015.1537.26-2.48
ROCE(%)11.4612.8918.3915.260.48
Total Debt/Equity(x)0.000.000.000.080.43

Key Financials

Market Cap : ₹ 307.0 Cr
Revenue (TTM) : ₹ 44.3 Cr
Net Profit(TTM) : ₹ 3.1 Cr
EPS (TTM) : ₹ 0.5
P/E (TTM) : 99.8

Industry Peers & Returns1W1M1Y
ZENOTECH LABORATORIES -1.2% -0.2% -36.1%
SUN PHARMACEUTICAL INDUSTRIES 2.8% 6.3% -1.1%
DIVIS LABORATORIES -2.1% -2.5% 12.2%
CIPLA 0% -3.3% 0.6%
TORRENT PHARMACEUTICALS -2.5% 4.2% 21.5%
DR REDDYS LABORATORIES 1.3% -0.5% -0.2%
MANKIND PHARMA -1.5% -10.3% -12.1%
ZYDUS LIFESCIENCES -1.5% -5.8% -3.7%
LUPIN -1.4% 4.5% 0.4%


ZENOTECH LABORATORIES Revenues
[BOM: 532039]

Y-o-Y

-3.75 %

5 Yr CAGR

11.92 %

Years Revenues % Change
Mar2025 ₹41 Cr
-3.75
Mar2024 ₹42 Cr
16.02
Mar2023 ₹37 Cr
62.91
Mar2022 ₹22 Cr
-13.74
Mar2021 ₹26 Cr -


ZENOTECH LABORATORIES Operating Profit
[BOM: 532039]

Y-o-Y

-16.84 %

5 Yr CAGR

17.67 %

Years Operating Profit % Change
Mar2025 ₹17 Cr
-16.84
Mar2024 ₹21 Cr
18.57
Mar2023 ₹17 Cr
173.68
Mar2022 ₹6.38 Cr
-28.95
Mar2021 ₹8.98 Cr -

Operating Margins
Y-o-Y

-13.61 %

5 Yr CAGR

5.13 %

Years Operating Margin% % Change
Mar2025 42.16%
-13.61
Mar2024 48.8%
2.20
Mar2023 47.75%
67.96
Mar2022 28.43%
-17.62
Mar2021 34.51% -

ZENOTECH LABORATORIES Profit After Tax
[BOM: 532039]

Y-o-Y

-28.36 %

5 Yr CAGR

-6.33 %

Years Profit After Tax % Change
Mar2025 ₹8.30 Cr
-28.36
Mar2024 ₹12 Cr
-47.76
Mar2023 ₹22 Cr
Positive
Mar2022 ₹-1.22 Cr
Negative
Mar2021 ₹11 Cr -

PAT Margins
Y-o-Y

-35.83 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2025 13.04 %
-35.83
Mar2024 20.32 %
-25.60
Mar2023 27.31 %
-54.97
Mar2022 60.65 %
Positive
Mar2021 -5.41 % -

ZENOTECH LABORATORIES Earnings Per Share (EPS)
[BOM: 532039]

Y-o-Y

-32.35 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2025 ₹0.92
-32.35
Mar2024 ₹1.36
-28.42
Mar2023 ₹1.90
-47.66
Mar2022 ₹3.63
Positive
Mar2021 ₹-0.20 -

ZENOTECH LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532039]

Y-o-Y

-11.09 %

5 Yr CAGR

121.05 %

Years ROCE % Change
Mar2025 11.46%
-11.09
Mar2024 12.89%
-29.91
Mar2023 18.39%
20.51
Mar2022 15.26%
3,079.17
Mar2021 0.48% -

ZENOTECH LABORATORIES Share Price vs Sensex

Current Share Price : ₹50.3
Current MarketCap: ₹ 307.0 Cr
Updated EOD on :Nov 20,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
ZENOTECH LABORATORIES

-1.2%

-0.2%

-36.1%

SENSEX

1.4%

2%

10.2%

ZENOTECH LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ZENOTECH LABORATORIES Financials


How the annual revenues of ZENOTECH LABORATORIES have changed ?

The Revenues of ZENOTECH LABORATORIES have decreased by -3.75% YoY .

How the Earnings per Share (EPS) of ZENOTECH LABORATORIES have changed?

The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by -32.35 % YoY .